SCHEMBL2279159

SCHEMBL2279159

CCC(O)(I)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1265463 0.82
SCHEMBL950532 0.78
SCHEMBL13862748 0.78
SCHEMBL18541784 0.78
SCHEMBL10786771 0.75
SCHEMBL10900736 0.75
SCHEMBL11231188 0.75
SCHEMBL16970019 0.72
SCHEMBL16970327 0.72
SCHEMBL16970315 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200236932-A1 POLYALCOHOL, CARBOHYDRATE, NUCLEOBASE AND NUCLEOTIDE COMPOSITIONS AND USES THEREOF ZHANG, CHUNBO 2020-07-30 US claimed
WO-2017053467-A1 POLYALCOHOL, CARBOHYDRATE, NUCLEOBASE AND NUCLEOSIDE COMPOSITIONS AND USES THEREOF COMBI-BLOCKS, INC. (US) 2017-03-30 WO claimed
US-20250367232-A1 HALOGEN TREATMENT OF HEART ATTACK AND ISCHEMIC INJURY HUTCHINSON FRED CANCER RES (US) 2025-12-04 US disclosed
US-12016880-B2 Halogen treatment of heart attack and ischemic injury FRED HUTCHINSON CANCER CENTER (US) 2024-06-25 US disclosed
EP-3104939-B1 TREATMENT OF HEART ATTACK AND ISCHEMIC INJURY WITH SODIUM IODIDE FRED HUTCHINSON CANCER CENTER (US) 2024-05-01 EP disclosed
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents COLABS INT'L CORP. (US) 2024-03-28 US disclosed
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents CoLabs International Corporation (US) 2023-12-12 US disclosed
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CoLabs International Corporation (US) 2023-08-15 US disclosed
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent COLABS INT'L CORP. (US) 2023-07-25 US disclosed
US-20230113098-A1 Compositions Containing a Capsule with an Agent COLABS INT'L CORP. (US) 2023-04-13 US disclosed
US-11553713-B2 Polyalcohol, carbohydrate, nucleobase and nucleotide compositions and uses thereof Zhang, Chunbo (US) 2023-01-17 US disclosed
CN-1019573-B PROCESS FOR PREPARING NITROHETEROCYCLIC ALKANE DERIVATIVES HISAMITSU PHARMACEUTICAL CO (JP) 1992-12-23 CN disclosed
EP-0241050-B1 AZACYCLOALKANE DERIVATIVES, ABSORPTION PROMOTERS CONTAINING THE DERIVATIVES AS THE EFFECTIVE INGREDIENT AND EXTERNAL PREPARATION CONTAINING THE ABSORPTION PROMOTERS HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1992-10-14 EP disclosed
CN-1018452-B PROCESS FOR PREPARING AZACYCLOALKANE DERIVATIVES HISAMITSU PHARMACEUTICAL CO (JP) 1992-09-30 CN disclosed
CN-1060465-A Process for preparing azacycloalkane derivatives HISAMITSU PHARMACEUTICAL CO (JP) 1992-04-22 CN disclosed
CN-1060287-A The method for preparing azacycloparaffin derivatives HISAMITSU PHARMACEUTICAL CO (JP) 1992-04-15 CN disclosed
US-4882359-A USED WITH DRUGS HISAMITSU PHARMACEUTICAL CO., LTD. (JP) 1989-11-21 US disclosed
CN-87100666-A Nitrogen heterocyclic derivative, absorption enhancer containing the derivative as active ingredient, and external preparation containing the absorption enhancer 1987-10-21 CN disclosed
EP-0241050-A2 Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparation containing the absorption promoters HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1987-10-14 EP disclosed
EP-0091305-A2 Method for producing vicinal, heterogeneous dihalogenated products, their use, and novel products CETUS CORPORATION (US) 1983-10-12 EP disclosed